Evaluation of Safety and Efficacy of Product
- Registration Number
- CTRI/2022/05/042724
- Lead Sponsor
- Kama Ayurveda Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1Indian male and female subjects
2Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
3Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar) Specific criteria
4Having oily & mixed oily skin (having acne prone skin) and combination skin type with acne lesions, blackhead, whiteheads & visible pores
1For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
2Having refused to give her/his assent by signing the consent form
3Taking part in another study liable to interfere with this study
4Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)
5Being asthmatic.
6Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex
7Following a chronic medicinal treatment comprising any of the following products: aspirin based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
8Having cutaneous hypersensitivity.
9Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
10Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
11Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.
12Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted)
13Refusing to follow the restrictions below during the study: For Females: Do not take part in any family planning activities leading to pregnancy and breastfeeding, Do not take part in another study liable to interfere with this study, Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol), Do not change his/her cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit., During the study: Do not use other cosmetic products than the tested products to the studied areas, Do not use hair oil ,The day of the measurements : No other cosmetic products must be used (only face cleaned with water is accepted)
14In the 6 previous months ,Having started, changed or stopped a hormonal treatment (hormonal contraception, cyproterone acetate â?¦), Having taken an oral retinoid-based treatment
15In the previous month, Having undergone a physical (phototherapy, laser ..) or chemical (peeling) treatment for acne, Having had a local benzoyl-peroxide-based treatment or a local retinoid-based treatment,Having had an oral treatment with a base of cimetidine, zinc (gluconate of zinc) or spironolactone
16In the 2 previous weeks, Having applied cosmetic products with anti-seborrheic aims or cosmetics for oily skin, Having had oral or local antibiotic treatment for acne, Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask â?¦), Having a suntanned skin on the studied areas which could interfere with the evaluations of the study
17Refusing to follow the restrictions below during the study: Do not apply cosmetic products with anti-seborrheic aims or cosmetics for oily skin, Do not have beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask â?¦), Do not start, change or stop a hormonal treatment (hormonal contraception, cyproterone acetate â?¦), Do not start a local or general treatment acting on seborrhoea , Do not expose himself/herself to the sun, S
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in acne & <br/ ><br>acne PIH, improvement in skin texture (i.e., softness & smoothness), reduction in pore size, reduction <br/ ><br>in sebum content, improvement in skin brightenesssTimepoint: 15 minutes, 28 days
- Secondary Outcome Measures
Name Time Method Balancing skin pH and <br/ ><br>improvement in skin plumpnessTimepoint: 15 minutes, 28 days